Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:NDRA NASDAQ:NVNO NASDAQ:NXL OTCMKTS:RSLSD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNDRAENDRA Life Sciences$5.55-0.7%$4.66$2.91▼$11.96$7.05M-0.1178,437 shs20,635 shsNVNOenVVeno Medical$10.95+7.9%$10.98$8.67▼$196.70$7.32M1.0817,993 shs7,883 shsNXLNexalin Technology$0.34+4.4%$0.39$0.31▼$2.00$6.89M3.56436,961 shs183,882 shsRSLSDReShape Lifesciences$0.00$2.91▼$82.80$1.90M2.031,362 shs6,500 shs7 Stocks to Ride The A.I. MegaboomWe are about to experience the greatest A.I. boom in stock market history... Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s. That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom. Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day. And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly... Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNDRAENDRA Life Sciences+3.33%-3.79%-12.66%+62.03%+72.53%NVNOenVVeno Medical+3.32%+8.91%-14.31%+5.62%-92.01%NXLNexalin Technology-1.08%-6.25%-30.71%-24.82%-74.72%RSLSDReShape Lifesciences0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNDRAENDRA Life Sciences$5.55-0.7%$4.66$2.91▼$11.96$7.05M-0.1178,437 shs20,635 shsNVNOenVVeno Medical$10.95+7.9%$10.98$8.67▼$196.70$7.32M1.0817,993 shs7,883 shsNXLNexalin Technology$0.34+4.4%$0.39$0.31▼$2.00$6.89M3.56436,961 shs183,882 shsRSLSDReShape Lifesciences$0.00$2.91▼$82.80$1.90M2.031,362 shs6,500 shs7 Stocks to Ride The A.I. MegaboomWe are about to experience the greatest A.I. boom in stock market history... Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s. That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom. Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day. And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly... Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNDRAENDRA Life Sciences+3.33%-3.79%-12.66%+62.03%+72.53%NVNOenVVeno Medical+3.32%+8.91%-14.31%+5.62%-92.01%NXLNexalin Technology-1.08%-6.25%-30.71%-24.82%-74.72%RSLSDReShape Lifesciences0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNDRAENDRA Life Sciences 2.00Hold$30.00440.54% UpsideNVNOenVVeno Medical 1.50ReduceN/AN/ANXLNexalin Technology 1.00SellN/AN/ARSLSDReShape Lifesciences 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest RSLSD, NDRA, NXL, and NVNO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/20/2026NDRAENDRA Life Sciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/27/2026NVNOenVVeno Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 5/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNDRAENDRA Life SciencesN/AN/AN/AN/A$1.41 per shareN/ANVNOenVVeno MedicalN/AN/AN/AN/A$35.57 per shareN/ANXLNexalin Technology$300K22.98N/AN/A$0.14 per share2.39RSLSDReShape Lifesciences$610K0.00N/A0.08$341.84 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNDRAENDRA Life Sciences-$7.03M-$8.15N/AN/AN/AN/A-433.64%-204.58%N/ANVNOenVVeno Medical-$19.47M-$25.54N/AN/AN/AN/A-66.39%-60.42%7/30/2026 (Estimated)NXLNexalin Technology-$8.22M-$0.47N/AN/AN/A-3,018.12%-191.88%-166.43%6/3/2026 (Estimated)RSLSDReShape Lifesciences-$81.15MN/AN/AN/AN/A-668.58%-163.22%-52.10%N/ALatest RSLSD, NDRA, NXL, and NVNO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/3/2026N/ANXLNexalin Technology-$0.10N/AN/AN/A$0.02 millionN/A5/18/2026Q1 2026NDRAENDRA Life Sciences-$1.23-$1.09+$0.14-$1.09N/AN/A5/8/2026Q1 2026NXLNexalin Technology-$0.10-$0.11-$0.01-$0.11$0.02 million$0.01 million5/7/2026Q1 2026NVNOenVVeno Medical-$8.40-$5.89+$2.51-$5.89$0.50 millionN/A3/25/2026Q4 2025NXLNexalin Technology-$0.12-$0.13-$0.01-$0.13$0.08 million$0.17 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthNDRAENDRA Life SciencesN/AN/AN/AN/AN/ANVNOenVVeno MedicalN/AN/AN/AN/AN/ANXLNexalin TechnologyN/AN/AN/AN/AN/ARSLSDReShape LifesciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNDRAENDRA Life SciencesN/A0.641.29NVNOenVVeno MedicalN/A11.8911.89NXLNexalin TechnologyN/A4.073.85RSLSDReShape Lifesciences0.051.171.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNDRAENDRA Life Sciences1.19%NVNOenVVeno Medical34.71%NXLNexalin Technology0.65%RSLSDReShape LifesciencesN/AInsider OwnershipCompanyInsider OwnershipNDRAENDRA Life Sciences10.00%NVNOenVVeno Medical15.00%NXLNexalin Technology25.26%RSLSDReShape LifesciencesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNDRAENDRA Life Sciences201.27 million1.12 millionNot OptionableNVNOenVVeno Medical30668,000568,000OptionableNXLNexalin Technology320.58 million15.38 millionNot OptionableRSLSDReShape Lifesciences50354,000N/ANot OptionableRSLSD, NDRA, NXL, and NVNO HeadlinesRecent News About These CompaniesInsider Selling: STANKOVICH THOMAS, ReShape Lifesciences Inc. [RSLS] Chief Financial Officer divested 106 sharesNovember 2, 2023 | knoxdaily.comKReShape Lifesciences (NASDAQ: RSLS) up 60% - But why in the name of….?October 27, 2023 | dhakatribune.comDReShape Lifesciences Inc. [RSLS] Shares Fall Approximately -98.23% Over the YearOctober 12, 2023 | knoxdaily.comKReShape Lifesciences Inc: ReShape Lifesciences Signs Exclusive License Agreement With Biorad Medisys for Obalon Gastric Balloon SystemSeptember 21, 2023 | finanznachrichten.deReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon SystemSeptember 21, 2023 | finance.yahoo.comRecent Insider Activity Could Benefit ReShape Lifesciences Inc. (RSLS)June 29, 2023 | knoxdaily.comKReShape Lifesciences® Submits FDA PMA Supplement Application for the Next-Generation Lap-Band® 2.0June 26, 2023 | finance.yahoo.comPotential Price Increase for ReShape Lifesciences Inc. (RSLS) After Recent Insider ActivityJune 19, 2023 | knoxdaily.comKReShape Lifesciences® to Participate in Investor and Industry Conferences in JuneJune 14, 2023 | finance.yahoo.comReShape Lifesciences Inc. (NASDAQ:RSLS) Q1 2023 Earnings Call TranscriptMay 17, 2023 | insidermonkey.comReShape Lifesciences® to Present Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the Keystone Symposia on Type 2 DiabetesApril 27, 2023 | markets.buffalonews.comMReShape Lifesciences Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-MarketApril 20, 2023 | finance.yahoo.comReShape Lifesciences(R) Receives Notice of Allowance for U.S. Patent Related to its Obalon(R) Balloon SystemApril 12, 2023 | marketwatch.comReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to its Obalon® Balloon SystemApril 11, 2023 | finance.yahoo.comReShape Lifesciences postpones earnings releaseMarch 31, 2023 | seekingalpha.comEarnings Outlook For Reshape LifesciencesMarch 28, 2023 | msn.comReShape Lifesciences Announces Closing of Upsized $10.2 Million Underwritten Public OfferingFebruary 8, 2023 | benzinga.comWhy Is Reshape Lifesciences (RSLS) Stock Up 136% Today?February 3, 2023 | msn.comReShape Lifesciences Inc. (RSLS) Q3 2022 Earnings Call TranscriptNovember 14, 2022 | seekingalpha.comReShape Lifesciences™ Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 14, 2022 | yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeRSLSD, NDRA, NXL, and NVNO Company DescriptionsENDRA Life Sciences NASDAQ:NDRA$5.55 -0.04 (-0.72%) Closing price 04:00 PM EasternExtended Trading$5.54 0.00 (-0.09%) As of 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.enVVeno Medical NASDAQ:NVNO$10.95 +0.80 (+7.88%) Closing price 04:00 PM EasternExtended Trading$10.83 -0.12 (-1.10%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). Deep venous CVI occurs when valves inside of the deep veins of the leg become damaged, resulting in insufficient blood being returned to the heart. The malfunctioning vein valves cause blood to flow backwards (reflux) and pool in the lower leg, increasing the pressure within the veins of the leg (venous hypertension). In the most severe cases, CVI can lead to venous ulcers (open skin sores) that become chronic and difficult to heal. The VenoValve is implanted in the femoral vein and works as a replacement venous valve, designed to reduce reflux and venous hypertension, and to restore proper directional blood flow back to the heart. With severe deep venous CVI impacting an estimated 2.4 million people in the U.S., who have no effective treatment options, the VenoValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial. Nexalin Technology NASDAQ:NXL$0.34 +0.01 (+4.36%) Closing price 04:00 PM EasternExtended Trading$0.33 0.00 (-0.30%) As of 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.ReShape Lifesciences OTCMKTS:RSLSDReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy; and Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook AI Consolidation Begins: Blackstone & Google Forge an AI Empire The Great AI Rotation: Cashing In on Data Mirum Pharma: A Rare Disease Growth Story to Watch Vertical Aerospace: Pre-Flight Checks Point to a Breakout HIVE Weaponizes Power for an AI Pivot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
